Advertisement

U.S. markets open in 16 minutes

S&P Futures
4,041.50
-43.25(-1.06%)
Dow Futures
32,326.00
-255.00(-0.78%)
Nasdaq Futures
12,379.50
-180.75(-1.44%)
Russell 2000 Futures
1,819.20
-18.00(-0.98%)
Crude Oil
114.27
+1.87(+1.66%)
Gold
1,811.40
-7.50(-0.41%)

Advertisement

Webinar

Yahoo Finance Plus presents 'Investing in the new high-inflation, slowing-growth paradigm'

Analyst Callie Cox joins Jared Blikre to help investors find opportunities in a tough market on Wed, May 18 at 2pm ET.

AngioDynamics, Inc. (ANGO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

20.28

+1.50

(+7.99%)

At close: 04:00PM EDT

20.28

0.00

(0.00%)

After hours:

04:02PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

Commodity Channel Index

View all chart patterns

Performance Outlook

Previous Close	18.78
Open	19.17
Bid	7.99 x 800
Ask	29.75 x 800
Day's Range	18.44 - 20.29
52 Week Range	17.56 - 32.00
Volume	195,658
Avg. Volume	240,311

Market Cap	786.46M
Beta (5Y Monthly)	0.92
PE Ratio (TTM)	N/A
EPS (TTM)	-1.02
Earnings Date	Jul 11, 2022 - Jul 15, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	36.00

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ANGO

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

AngioDynamics, Inc.
ANGO: Lowering target price to $15.00ANGIODYNAMICS INC has an Investment Rating of SELL; a target price of $15.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
Rating
Fair Value
Economic Moat
7 days agoArgus Research

All

Business Wire
AngioDynamics to Present at the UBS Global Healthcare Conference
LATHAM, N.Y., May 16, 2022--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the UBS Global Healthcare Conference at 4:15 p.m. ET on Monday
- Fiverr to Present at Upcoming Investor Conference
  Business Wire
- Talaris Therapeutics to Present at the H.C. Wainwright Global Investment Conference
  GlobeNewswire
Business Wire
AngioDynamics to Present at the BofA Securities Healthcare Conference
LATHAM, N.Y., May 03, 2022--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the BofA Securities Healthcare Conference at 10:00 a.m. PT (1:
Simply Wall St.
Swelling losses haven't held back gains for AngioDynamics (NASDAQ:ANGO) shareholders since they're up 35% over 5 years
The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up...